Leslie Harrold, MD, MPH

Chief Scientific Officer
CorEvitas, LLC, United States

CorEvitas, LLC (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Using Bias Correction Methods with Hybrid Randomized Controlled Trial (RCT) Plus Real World (RW) Controls to Replicate Results of a Phase Iib RCT of Baricitinib for Rheumatoid Arthritis (RA)

  Friday, August 26, 2022
  1:30 PM – 1:45 PM CEST